XPO1 and neoplasm: In this study, we are the first to report that XPO1 inhibition (by RNAi or selinexor) can up-regulate the expression of tumor suppressive miR-145 and, in turn, down-regulate the expression of its target pathways, leading to the inhibition of proliferation and migration of PDAC cells.